Insiders · Profile

Hill Stephen J.

Chief Operating Officer at Lyell Immunopharma. Filing since 11 Aug 2025. CIK 0001866154

Company
Date
Role
Action
Shares
Amount
Of holding
21 Aug 2026
Chief Operating Officer
Sold at will
989
$15.37K
5.6%
10 Aug 2026
Chief Operating Officer
Sold at will
89
$1.28K
0.5%
11 May 2026
Chief Operating Officer
Sold at will
89
$1.68K
0.5%
11 Feb 2026
Chief Operating Officer
Sold at will
1,236
$28.91K
6.5%
10 Feb 2026
Chief Operating Officer
Sold at will
109
$2.52K
0.6%
10 Nov 2025
Chief Operating Officer
Sold at will
95
$1.53K
0.6%
21 Aug 2025
Chief Operating Officer
Sold at will
1,004
$10.59K
6.0%
12 Aug 2025
Chief Operating Officer
Sold at will
94
$971.77
1.1%
11 Aug 2025
Chief Operating Officer
Sold at will
91
$957.87
1.0%
9 decisions on file.